Nov. 18, 2024
Revenue from Operations of ₹17,376 million
Profit Before Tax of ₹1,901 million
Bayer CropScience Limited (BSE: 506285) announced its unaudited results for the quarter (Q2) and half year ended (H1) September 30, 2024.
For Q2 ended September 30, 2024, Bayer CropScience Limited (BCSL) registered Revenue from Operations of ₹17,376 million as compared to ₹16,172 million in the corresponding period of FY 2023-24. Profit Before Tax stood at ₹1,901 million, compared to ₹3,057 million in the corresponding period of the previous financial year.
For the H1 ended September 30, 2024, BCSL reported Revenue from Operations of ₹33,688 million compared to ₹33,568 million for the corresponding period in FY 2023-24. Profit Before Tax for the H1 ended September 30, 2024, stood at ₹5,059 million, compared to ₹7,118 million for the corresponding period in FY 2023-24.
Commenting on the quarterly results, Simon Wiebusch, Vice Chairman & Managing Director and CEO, BCSL said, ″In Q2 BCSL achieved a 7% increase in Revenue from Operations primarily driven by higher volumes which were partially offset by price pressure rooted in lower producer prices in China. Moreover, our margins were negatively impacted by higher production costs in corn seeds due to adverse weather conditions as well as a higher cost of goods sold in our chemical business. Despite these headwinds, we are looking forward to a stronger rabi and spring season, delivering sustainable, long-term value for our stakeholders.″
Speaking about the quarterly results, Simon Britsch, Chief Financial Officer, BCSL said, ″We maintain our strong focus on cash flow generation and prudent operational expense management. However, we witnessed one-time effects from higher receivables and employee severance provisions. As we look forward, we are confident in our ability to continue with further growth investments and distributing a significant share of our profit to our owners.″
The Board of Directors at its meeting held on November 13, 2024, declared an interim dividend of ₹ 90/- per equity share for the financial year ending March 31, 2025, amounting to ₹ 4,045 Million.
Subscribe Email: | * | |
Name: | ||
Mobile Number: | ||
0/1200